Strain Data Sheet

RBRC05323

Strain Information

Image
BRC No.RBRC05323
TypeTargeted MutationCartagena
SpeciesMus musculus
Strain name129-Sirt1<tm1Mcby>
Former Common nameSTOCK Sirt1<tm1Mcby>
H-2 Haplotype
ES Cell lineR1 [(129X1/SvJ x 129S1/Sv)F1-Kitl<+>]
Background strain
Appearance
Strain developmentDeveloped by Michael McBurney, Ottawa Regional Cancer Centre and Department of Medicine, University of Ottawa. A hygromycin resistance cassette was inserted to replace exons 5 and 6. 129 background.
Strain descriptionSirT1 knockout mice. A hygromycin resistance cassette was inserted to replace exons 5 and 6 of Sirt1 gene. Homozygous mutant mice die at birth. When outbred to CD1, SirT1 KO mice have short snouts, eyelid defect and are smaller than littermates at weaning.
Colony maintenanceHeterozygote X Wild-type
References
The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis.
McBurney M W, Yang X, Jardine K, Hixon M, Boekelheide K, Webb J R, Lansdorp P M, Lemieux M
Mol. Cell. Biol., 23, 38-54 (2003). 12482959

Health Report

Examination Date / Room / Rack

Gene

Gene SymbolGene NameChr.Allele SymbolAllele NameCommon NamesPromoterDiseases Related to This Gene
Hyg hygromycin phasphotransferase (E. coli)10Hyg herpes simplex virus thymidine kinase promoter (HSV tk promoter)
IRES internal ribosomal entry site (EMCV)10
Sirt1
MGI:2135607
sirtuin 110Sirt1<tm1Mcby>
MGI:2448246
targeted mutation 1, Michael W McBurney

Phenotype

Annotation by Mammalian phenotyhpe ontology
  • abnormal Leydig cell morphology(MP:0002786)

  • abnormal Sertoli cell development(MP:0004109)

  • abnormal adult Leydig cell differentiation(MP:0013604)

  • abnormal cellular respiration(MP:0010954)

  • abnormal digit development(MP:0006280)
  • more 72 phenotypes
  • abnormal estrous cycle(MP:0001927)

  • abnormal eyelid morphology(MP:0001340)

  • abnormal glucose tolerance(MP:0005291)

  • abnormal inguinal fat pad morphology(MP:0005336)

  • abnormal lacrimal gland morphology(MP:0001346)

  • abnormal male germ cell apoptosis(MP:0008280)

  • abnormal nursing(MP:0001382)

  • abnormal palatal rugae morphology(MP:0009652)

  • abnormal renal glomerulus morphology(MP:0005325)

  • abnormal salivary gland morphology(MP:0000613)

  • abnormal seminiferous tubule epithelium morphology(MP:0011750)

  • abnormal seminiferous tubule morphology(MP:0002216)

  • abnormal sperm flagellum morphology(MP:0008892)

  • abnormal spermatid morphology(MP:0006380)

  • abnormal spermatocyte morphology(MP:0006379)

  • abnormal testes secretion(MP:0002782)

  • abnormal uterus size(MP:0004902)

  • absent corpus luteum(MP:0001134)

  • absent estrous cycle(MP:0009009)

  • anovulation(MP:0008869)

  • arrest of male meiosis(MP:0008261)

  • arrest of spermatogenesis(MP:0001155)

  • asthenozoospermia(MP:0002675)

  • decreased CD8-positive, alpha-beta T cell number(MP:0008079)

  • decreased Leydig cell number(MP:0005536)

  • decreased body size(MP:0001265)

  • decreased body weight(MP:0001262)

  • decreased brain weight(MP:0002175)

  • decreased circulating follicle stimulating hormone level(MP:0002790)

  • decreased circulating luteinizing hormone level(MP:0002773)

  • decreased circulating thyroxine level(MP:0005478)

  • decreased embryo size(MP:0001698)

  • decreased locomotor activity(MP:0001402)

  • decreased testis weight(MP:0004852)

  • decreased urine osmolality(MP:0002988)

  • exocrine pancreas atrophy(MP:0009164)

  • eyelids fail to open(MP:0005176)

  • female infertility(MP:0001926)

  • globozoospermia(MP:0002686)

  • glomerulonephritis(MP:0002743)

  • heart right ventricle hypertrophy(MP:0000276)

  • hyperpnea(MP:0010946)

  • increased anti-nuclear antigen antibody level(MP:0004794)

  • increased autoantibody level(MP:0003725)

  • increased immunoglobulin level(MP:0002461)

  • increased insulin secretion(MP:0003058)

  • increased oxygen consumption(MP:0005289)

  • increased urine antidiuretic hormone level(MP:0011543)

  • interstitial pneumonia(MP:0001862)

  • lethargy(MP:0005202)

  • lung inflammation(MP:0001861)

  • male infertility(MP:0001925)

  • microphthalmia(MP:0001297)

  • multinucleated giant male germ cells(MP:0020550)

  • ocular hypotelorism(MP:0006197)

  • oligozoospermia(MP:0002687)

  • perinatal lethality(MP:0002081)

  • perinatal lethality, incomplete penetrance(MP:0011090)

  • polydipsia(MP:0001426)

  • polyphagia(MP:0001433)

  • postnatal growth retardation(MP:0001732)

  • postnatal lethality, complete penetrance(MP:0011085)

  • premature death(MP:0002083)

  • pulmonary edema(MP:0003828)

  • reduced female fertility(MP:0001923)

  • renal glomerular immunoglobulin deposits(MP:0020519)

  • reproductive system phenotype(MP:0005389)

  • short snout(MP:0000445)

  • slow postnatal weight gain(MP:0008489)

  • small ovary(MP:0001127)

  • small seminiferous tubules(MP:0001153)

  • teratozoospermia(MP:0005578)
  • Detailed phenotype data

    Ordering Information

    Donor DNAmouse Pgk1 splice acceptor (SA), Encephalomyocarditis virus (EMCV) internal ribosomal entry site (ires), herpes simplex virus thymidine kinase promoter (HSV tk promoter), E. coli Hygromycin resistance gene, mouse Pgk1 splice donor (SD), mouse Sirt1 genomic DNA
    Research application
    Specific Term and ConditionsIn publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.  The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR.
    DepositorMichael W. McBurney (Ottawa Hospital Research Institute)
    Strain Statusan icon for Frozen embryosFrozen embryos
    an icon for Frozen spermFrozen sperm
    Strain AvailabilityRecovered litters from cryopreserved embryos (2 to 4 months)
    Cryopreserved sperm (within 1 month)
    Cryopreserved embryos (within 1 month)
    Additional Info.Necessary documents for ordering:
    1. Order form (Japanese / English)
    2. Category I MTA: MTA for distribution with RIKEN BRC (Japanese / English)
    3. Acceptance of responsibility for living modified organism (Japanese / English)

    Genotyping protocol -PCR-

    BRC mice in Publications

    Kumar A, Daitsh Y, Ben-Aderet L, Qiq O, Elayyan J, Batshon G, Reich E, Maatuf YH, Engel S, Dvir-Ginzberg M.
    A predicted unstructured C-terminal loop domain in SIRT1 is required for cathepsin B cleavage.
    J Cell Sci 131(16) (2018) 30054388
    Tomita T, Hamazaki J, Hirayama S, McBurney MW, Yashiroda H, Murata S.
    Sirt1-deficiency causes defective protein quality control.
    Sci Rep 5 12613(2015) 26219988